Table 1. Recommendations for fetal echocardiography in high-risk pregnancies5–9 .
Recommendations | Recommendation class | Evidence level |
---|---|---|
Pre-gestational DM | I | A |
GDM diagnosed in first trimester | II | B |
Maternal phenylketonuria | I | A |
Maternal SSA/SSB antibodies | IIa | B |
Maternal medications: ACE inhibitors Retinoic acid NSAID in third trimester |
IIa I I |
B B A |
Maternal rubella infection in first trimester | I | C |
Maternal infection with suspicion of myocarditis/pericarditis | I | C |
Assisted reproduction | IIa | A |
Congenital heart disease in first-degree relative | I | B |
Heart disease with Mendelian inheritance in first or second-degree relative | I | C |
Suspicion of heart disease on obstetric ultrasound | I | B |
Extracardiac fetal anomaly | I | B |
Fetus with chromosome abnormality | I | C |
Fetus with tachycardia or bradycardia or frequent irregular heartbeats | I | C |
NT > 95% | I | A |
Monochorionic twinning | I | A |
Fetus with hydrops or effusions | I | B |
ACE: angiotensin-converting enzyme; DM: diabetes mellitus; GDM: gestational diabetes mellitus; NSAID: nonsteroidal anti-inflammatory drugs; NT: nuchal translucency. Adapted from Donafrio et al.7